Brett Winton, ARK's Chief Futurist and a leading voice in technology, shares insights on the frontier of quantum computing and AI in drug development. The discussion kicks off with Google's groundbreaking quantum chip announcement, unveiling its enormous potential. They tackle the unique challenges facing quantum tech and explore the exciting collaboration between GlaxoSmithKline and Relation Therapeutics. Winton emphasizes AI's role in transforming drug trials, aiming for reduced costs and better patient outcomes, sparking a shift in the pharmaceutical landscape.
31:17
forum Ask episode
web_stories AI Snips
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
insights INSIGHT
Quantum Computing's Commercial Viability
Quantum computing is commercially 15 years out, despite advancements.
Current "commercial partnerships" are mostly marketing for fundraising.
insights INSIGHT
Quantum Qubits
Quantum qubits exist in a state of both 0 and 1 simultaneously, unlike traditional bits.
This allows quantum computers to resolve complex calculations at once, potentially breaking encryption and advancing material science.
insights INSIGHT
Quantum vs. AI
Quantum computing advancements are promising but still experimental.
AI's rapid progress is capturing some markets initially envisioned for quantum computing.
Get the Snipd Podcast app to discover more snips from this episode
Is quantum computing the next big thing? This week, Autonomous Technology and Robotics Director of Research Sam Korus and Associate Portfolio Manager Nick Grous are joined by ARK Chief Futurist Brett Winton to discuss the latest advancements in quantum computing and AI drug discovery. They discuss Google's recent quantum chip announcement, the challenges of scaling quantum technology, and the potential applications in drug discovery. The conversation shifts to the partnership between GlaxoSmithKline and Relation Therapeutics, highlighting the promise of AI in revolutionizing drug development processes, reducing costs, and improving efficiency. The episode concludes with insights on the future of drug development and the potential for significant market changes in the pharmaceutical industry.
If you know ARK, then you probably know about our long-term research projections, like estimating where we will be 5-10 years from now! But just because we are long-term investors, doesn’t mean we don’t have strong views and opinions on breaking news. In fact, we discuss and debate this every day. So now we’re sharing some of these internal discussions with you in our new video series, “The Brainstorm”, a co-production from ARK and Public.com. Tune in every week as we react to the latest in innovation. Here and there we’ll be joined by special guests, but ultimately this is our chance to join the conversation and share ARK’s quick takes on what’s going on in tech today.
Key Points From This Episode:
Quantum computing is still 15 years away from commercial viability.
AI is transforming drug discovery, making it faster and cheaper.
AI drug discovery could reduce development costs to $600 million.
The future of healthcare may focus on curing diseases rather than just treating them.
FYI - For Your Innovation